NCT04357574Enrolling by invitation
Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19
Assessing the Provider Implementation and Experience of TeleHealth During COVID-19 and Impact on Acute Encounters
Source: ClinicalTrials.gov · Last updated 6 Feb 2026
Brief summary (registry, in English)
The primary objective of this research study is to assess Radiation Oncology healthcare providers (i.e. faculty, residents and advanced practice providers (APPs) implementation and perception of telehealth for on treatment patients in lieu of in person on treatment visits during standard of care radiotherapy during COVID-19.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 20 Apr 2020
- Start date
- 14 Apr 2020
- Primary completion date
- Apr 2027
- Lead sponsor
- Duke University
- NCT number
- NCT04357574
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 14 Apr 2020 to the primary completion date, Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- undergoing total body radiation therapy for hematopoetic stem cell transplantation
- undergoing therapy as inpatient
- completed radiation therapy prior to algorithm execution
Who the study is looking for
- started outpatient radiation therapy with or without concurrent systemic therapy at Duke Cancer Center during the COVID-19 outbreak
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Duke Cancer Center Coordinator of this site? Confirm its status | Durham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.